Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
Heng Fai Ambrose Chan - 03 Sep 2026 SCHEDULE 13D/A Report for DSS, INC. Common Stock, par value $0.02 per share (DSS)
- Filing manager
- Heng Fai Ambrose Chan
- Reporting owner
- Heng Fai Ambrose Chan
- Beneficially owned shares
- 26,311,715 shares
- Large-stake signal
-
Ownership
86%Beneficial ownership of this reported class.
Shares
26,311,715 sharesShares beneficially owned as disclosed.
Event date
03 Sep 2026Date tied to the ownership event or amendment.
Accepted by SEC
08 Sep 2026EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 86%
- Symbol
- DSS
- Shares outstanding
- 30,488,662 shares
- SEC form
- SCHEDULE 13D/A
- Accepted by SEC
- 08 Sep 2026, 21:14:22 UTC
- Event date
- 03 Sep 2026
- Prior SEC filing
- 09 Jul 2026
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
5 source fields
Key filing fact
Heng Fai Ambrose Chan disclosed 86% ownership in DSS, INC. Common Stock, par value $0.02 per share (DSS) on 03 Sep 2026.
Key facts
- Heng Fai Ambrose Chan filed SCHEDULE 13D/A for DSS, INC. Common Stock, par value $0.02 per share (DSS).
- Disclosed ownership: 86%.
- Date of event: 03 Sep 2026.
Change
- Previous schedule filing date: 09 Jul 2026.
- Current filing was accepted on 08 Sep 2026, 21:14.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (4)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Heng Fai Ambrose Chan | 86% | 26,311,715 | 26,311,715 | 0 | /s/ Heng Fai Ambrose Chan | Heng Fai Ambrose Chan, an Individual | 0001261725 |
| Alset Inc. | 80% | 24,407,472 | 24,407,472 | 0 | /s/ Heng Fai Ambrose Chan | Heng Fai Ambrose Chan, Chief Executive Officer, Alset Inc. | 0001750106 |
| Global Biomedical Pte. Ltd. | 3.1% | 311,634 | 311,634 | 0 | /s/ Heng Fai Ambrose Chan | Heng Fai Ambrose Chan, Director, Global Biomedical Pte. Ltd. | 0001823066 |
| Alset International Limited | 71% | 21,244,809 | 21,244,809 | 0 | /s/ Heng Fai Ambrose Chan | Heng Fai Ambrose Chan, Chief Executive Officer, Alset International Limited | 0001660984 |
CIK / CUSIP context first